Rohm Labs Tirzepatide 25mg/ml

Rohm Labs Tirzepatide 25mg/ml stands as a high-purity research peptide designed for advanced laboratory investigations into metabolic disorders and glucose regulation. This dual–agonist compound serves as a critical tool for scientists studying the intersection of diabetes, obesity, and cardiovascular health in controlled in vitro and animal models. Researchers utilize this specific 25mg/ml concentration to conduct precise dose-response analyses and evaluate long-term physiological effects without the variability found in clinical settings. The product adheres to strict manufacturing standards, ensuring data integrity and reproducibility across all experimental protocols.

Key Features

Manufactured by Rohm Labs, a trusted name in high-quality research peptides
High concentration of 25mg/ml allows for extended study periods and precise dilution
Dual-agonist mechanism targeting both GIP and GLP-1 receptors for comprehensive metabolic research
Supplied in sterile, sealed vials to prevent contamination and ensure compound stability
Includes unique verification codes for batch tracking and authenticity confirmation
Formulated exclusively for non-human research, in vitro studies, and animal models
Produced in ISO-compliant facilities under rigorous quality control measures
Supports research into obesity, type 2 diabetes, and related metabolic syndromes

Product Specifications

Product Name: Tirzepatide
Manufacturer: Rohm Labs
Concentration: 25mg/ml
Chemical Structure: Synthetic peptide (Dual GIP/GLP-1 Receptor Agonist)
CAS Number: 2023788-19-2
Package Type: Sealed glass vial with rubber stopper and aluminum seal
Storage Requirements: Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
Shelf Life: 2 years from manufacturing date when stored under recommended conditions
Purity Level: ≥99% (verified by HPLC and mass spectrometry)
Intended Use: Laboratory research only; strictly not for human consumption

Mechanism of Action

Tirzepatide functions as a potent dual agonist at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In research models, this compound binds to these specific receptors, activating signaling pathways that mimic endogenous incretin hormones. The activation of GLP-1 receptors stimulates insulin secretion in a glucose-dependent manner while suppressing glucagon release. Simultaneously, GIP receptor activation enhances insulin sensitivity and promotes lipid metabolism regulation. This dual mechanism creates a synergistic effect that single-receptor agonists cannot achieve. Scientists study this unique interaction to understand how simultaneous receptor activation influences cellular energy balance, appetite regulation centers in the brain, and overall metabolic homeostasis. The 25mg/ml concentration enables researchers to investigate the threshold levels required for receptor saturation and downstream signaling cascade activation.

Metabolic Impact

Research involving Tirzepatide reveals profound effects on metabolic parameters in animal and cellular models. Studies indicate significant reductions in body weight through suppressed appetite and increased energy expenditure. The compound alters substrate utilization, shifting metabolic preference away from fat storage toward fat oxidation. Researchers observe improved glucose tolerance and enhanced insulin sensitivity in diabetic models exposed to Tirzepatide. Lipid profiles show marked improvements, with reductions in triglycerides and LDL cholesterol levels. The peptide influences adipose tissue biology, reducing inflammation and improving metabolic function in obese models. These metabolic shifts provide crucial data for understanding the pathophysiology of metabolic syndrome and developing potential therapeutic strategies. The high concentration allows for detailed analysis of dose-dependent metabolic changes and long-term safety profiles in preclinical settings.

Where to Buy

Researchers acquire Rohm Labs Tirzepatide 25mg/ml through authorized chemical suppliers and verified laboratory distribution networks. Legitimate vendors require proof of institutional affiliation or research credentials before processing orders. Purchasing directly from Rohm Labs’ official partners guarantees product authenticity and proper cold-chain shipping. Academic institutions, private research labs, and qualified professionals must maintain compliance with local regulations regarding peptide acquisition. Online chemical catalogs list this item under research-only categories with strict shipping protocols to prevent degradation. Buyers should verify that suppliers provide certificates of analysis, batch testing documentation, and temperature-controlled transport history. Avoid unverified sources lacking proper storage capabilities or authenticity verification.

Conclusion

Rohm Labs Tirzepatide 25mg/ml represents a vital resource for advancing scientific knowledge in metabolic disease research. Its dual-agonist properties and high purity enable groundbreaking studies on obesity, diabetes, and cardiovascular health. Researchers rely on this compound to uncover mechanisms that could lead to future medical innovations. Proper storage and adherence to research guidelines ensure the validity of experimental outcomes. Continued investigation of Tirzepatide drives progress in understanding complex metabolic disorders.